Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing
Clémence T. B. Pasmans, Bastiaan B.J. Tops, Elisabeth M. P. Steeghs, Veerle M.H. Coupé, Katrien Grünberg, Eiko K. de Jong, Ed Schuuring, Stefan M. Willems, Marjolijn J. L. Ligtenberg, Valesca P. Retèl, Hans van Snellenberg, Ewart de Bruijn, Edwin Cuppen, Geert Frederix
Abstract
: This study outlined in detail all costing aspects and cost prices of current and new diagnostic modalities used in treatment of NSCLC, melanoma, CRC, and GIST in the Netherlands. Detailed cost differences and value comparisons between these diagnostic techniques enable future economic evaluations to support decision-making.
Topics & Concepts
Activity-based costingMedicineSanger sequencingPrecision medicineOncologyMedical physicsDNA sequencingBusinessPathologyBiologyGeneticsDNAMarketingCancer Genomics and DiagnosticsGenetic factors in colorectal cancerColorectal Cancer Treatments and Studies